BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for CTI BioPharma Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-28 1:51 pm Sale | 2023-06-26 | 13D | CTI BioPharma Corp. CTIC | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -28,463,021 (Position Closed) | Filing |
| 2022-08-11 4:48 pm Purchase | 2022-08-09 | 13D | CTI BioPharma Corp. CTIC | BIOTECHNOLOGY VALUE FUND L P | 28,463,021 19.990% | 11,339,998 (+66.23%) | Filing |
| 2021-03-15 07:55 am Purchase | 2021-03-10 | 13D | CTI BioPharma Corp. CTIC | BIOTECHNOLOGY VALUE FUND L P | 17,123,023 19.990% | 4,369,333 (+34.26%) | Filing |